320 related articles for article (PubMed ID: 30616618)
1. Disruption of the hippocampal and hypothalamic blood-brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate.
Salameh TS; Mortell WG; Logsdon AF; Butterfield DA; Banks WA
Fluids Barriers CNS; 2019 Jan; 16(1):1. PubMed ID: 30616618
[TBL] [Abstract][Full Text] [Related]
2. Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.
Price TO; Eranki V; Banks WA; Ercal N; Shah GN
Endocrinology; 2012 Jan; 153(1):362-72. PubMed ID: 22109883
[TBL] [Abstract][Full Text] [Related]
3. Blood-Brain Barrier Disruption and Neurovascular Unit Dysfunction in Diabetic Mice: Protection with the Mitochondrial Carbonic Anhydrase Inhibitor Topiramate.
Salameh TS; Shah GN; Price TO; Hayden MR; Banks WA
J Pharmacol Exp Ther; 2016 Dec; 359(3):452-459. PubMed ID: 27729477
[TBL] [Abstract][Full Text] [Related]
4. High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: Implications for cerebral microvascular disease in diabetes.
Shah GN; Morofuji Y; Banks WA; Price TO
Biochem Biophys Res Commun; 2013 Oct; 440(2):354-8. PubMed ID: 24076121
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M
Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480
[TBL] [Abstract][Full Text] [Related]
6. One-week exposure to a free-choice high-fat high-sugar diet does not disrupt blood-brain barrier permeability in fed or overnight fasted rats.
Rijnsburger M; Unmehopa UA; Eggels L; Serlie MJ; la Fleur SE
Nutr Neurosci; 2019 Aug; 22(8):541-550. PubMed ID: 29284375
[No Abstract] [Full Text] [Related]
7. Endothelial Adora2a Activation Promotes Blood-Brain Barrier Breakdown and Cognitive Impairment in Mice with Diet-Induced Insulin Resistance.
Yamamoto M; Guo DH; Hernandez CM; Stranahan AM
J Neurosci; 2019 May; 39(21):4179-4192. PubMed ID: 30886019
[TBL] [Abstract][Full Text] [Related]
8. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of S-nitrosoglutathione administration against hyperglycemia induced disruption of blood brain barrier is mediated by modulation of tight junction proteins and cell adhesion molecules.
Aggarwal A; Singh I; Sandhir R
Neurochem Int; 2018 Sep; 118():205-216. PubMed ID: 29792953
[TBL] [Abstract][Full Text] [Related]
10. Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA
Acharya NK; Qi X; Goldwaser EL; Godsey GA; Wu H; Kosciuk MC; Freeman TA; Macphee CH; Wilensky RL; Venkataraman V; Nagele RG
Diab Vasc Dis Res; 2017 May; 14(3):200-213. PubMed ID: 28301218
[TBL] [Abstract][Full Text] [Related]
11. Occipital blood-brain barrier permeability is an independent predictor of visual outcome in type 2 diabetes, irrespective of the retinal barrier: A longitudinal study.
Abuhaiba SI; Cordeiro M; Amorim A; Cruz Â; Quendera B; Ferreira C; Ribeiro L; Bernardes R; Castelo-Branco M
J Neuroendocrinol; 2018 Jan; 30(1):. PubMed ID: 29247551
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of bucillamine on increased blood-retinal barrier permeability in streptozotocin-induced diabetic rats.
Hikichi T; Mori F; Nakamura M; Shishido N; Sasaki M; Horikawa Y; Yoshida A
Curr Eye Res; 2002 Jul; 25(1):1-7. PubMed ID: 12518237
[TBL] [Abstract][Full Text] [Related]
13. The Blood-Brain Barrier Interface in Diabetes Mellitus: Dysfunctions, Mechanisms and Approaches to Treatment.
Banks WA
Curr Pharm Des; 2020; 26(13):1438-1447. PubMed ID: 32209037
[TBL] [Abstract][Full Text] [Related]
14. Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.
VanGilder RL; Kelly KA; Chua MD; Ptachcinski RL; Huber JD
Exp Brain Res; 2009 Jul; 197(1):23-34. PubMed ID: 19565232
[TBL] [Abstract][Full Text] [Related]
15. HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice.
Zhao Q; Zhang F; Yu Z; Guo S; Liu N; Jiang Y; Lo EH; Xu Y; Wang X
J Neuroinflammation; 2019 May; 16(1):103. PubMed ID: 31101061
[TBL] [Abstract][Full Text] [Related]
16. Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats.
Mooradian AD; Haas MJ; Batejko O; Hovsepyan M; Feman SS
Diabetes; 2005 Oct; 54(10):2977-82. PubMed ID: 16186401
[TBL] [Abstract][Full Text] [Related]
17. Fluorescein Permeability of the Blood-Brain Barrier Is Enhanced in Juvenile- but Not Young Adult-Onset Type 1 Diabetes in Rats.
Tsuneoka Y; Nishimura T; Oka JI
Biol Pharm Bull; 2021; 44(8):1088-1092. PubMed ID: 34334494
[TBL] [Abstract][Full Text] [Related]
18. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
20. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.
Rudraraju M; Narayanan SP; Somanath PR
Pharmacol Res; 2020 Nov; 161():105115. PubMed ID: 32750417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
